HOCOR Cardiovascular Technologies

Our life-saving temporary heart valve catheter is 10 pigs away from FDA approval for human use.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Honolulu, HI, USA
  • Currency USD
  • Founded August 2007
  • Employees 1
  • Incorporation Type LLC
  • Website hocorcardiovascular.com

Company Summary

HOCOR’s temporary heart valve can save your life in an emergency if the needed heart surgery is not readily available. Our invention has been awarded 10 patents (8 US, 2 EU). The technology has been clincally validated in 8 journal publications and recognized in 3 startup awards. According to the FDA, we are only 10 pig-testings before allowing for human use. The cost of this final step is about $750,000.

Team

  • Paul C. Ho
    Founder, owner

    Founder and inventor of the HOCOR system, Dr. Ho practices Clinical and Interventional Cardiology in Hawaii and has performed over 10,000 cardiac procedures. He has been involved in numerous clinical trials of heart devices. Trained as a Biomedical Engineer at the University of Pennsylvania, he received his Medicine and Cardiology training at Dartmouth and Harvard Medical Schools.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free